Selected article for: "current development and long term"
Author: Miethke, Marcus; Pieroni, Marco; Weber, Tilmann; Brönstrup, Mark; Hammann, Peter; Halby, Ludovic; Arimondo, Paola B.; Glaser, Philippe; Aigle, Bertrand; Bode, Helge B.; Moreira, Rui; Li, Yanyan; Luzhetskyy, Andriy; Medema, Marnix H.; Pernodet, Jean-Luc; Stadler, Marc; Tormo, José Rubén; Genilloud, Olga; Truman, Andrew W.; Weissman, Kira J.; Takano, Eriko; Sabatini, Stefano; Stegmann, Evi; Brötz-Oesterhelt, Heike; Wohlleben, Wolfgang; Seemann, Myriam; Empting, Martin; Hirsch, Anna K. H.; Loretz, Brigitta; Lehr, Claus-Michael; Titz, Alexander; Herrmann, Jennifer; Jaeger, Timo; Alt, Silke; Hesterkamp, Thomas; Winterhalter, Mathias; Schiefer, Andrea; Pfarr, Kenneth; Hoerauf, Achim; Graz, Heather; Graz, Michael; Lindvall, Mika; Ramurthy, Savithri; Karlén, Anders; van Dongen, Maarten; Petkovic, Hrvoje; Keller, Andreas; Peyrane, Frédéric; Donadio, Stefano; Fraisse, Laurent; Piddock, Laura J. V.; Gilbert, Ian H.; Moser, Heinz E.; Müller, Rolf
Title: Towards the sustainable discovery and development of new antibiotics
  • Cord-id: ljb3cu21
  • Document date: 2021_8_19
    • ID: ljb3cu21
    Snippet: An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the current level of investment in their development, particularly in the fields of natural-product-derived and synthetic small molecules. New agents displaying innovative chemistry and modes of action are desperately needed worldwide to tackle the public health menace posed by antimicrobial resistance. Here, ou
    Document: An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the current level of investment in their development, particularly in the fields of natural-product-derived and synthetic small molecules. New agents displaying innovative chemistry and modes of action are desperately needed worldwide to tackle the public health menace posed by antimicrobial resistance. Here, our consortium presents a strategic blueprint to substantially improve our ability to discover and develop new antibiotics. We propose both short-term and long-term solutions to overcome the most urgent limitations in the various sectors of research and funding, aiming to bridge the gap between academic, industrial and political stakeholders, and to unite interdisciplinary expertise in order to efficiently fuel the translational pipeline for the benefit of future generations. [Image: see text]

    Search related documents:
    Co phrase search for related documents
    • academia industry and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • academic industrial and machine learning: 1, 2, 3, 4, 5, 6
    • academic perspective and machine learning: 1
    • academic project and machine learning: 1
    • academic research and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • action plan and machine learning: 1, 2, 3
    • additional resource and machine learning: 1
    • additional technique and machine learning: 1, 2
    • adjunctive therapy and machine learning: 1
    • low development and machine learning: 1, 2, 3, 4, 5, 6, 7
    • low percentage and machine learning: 1, 2, 3, 4, 5
    • lung infection and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • lung infection model and machine learning: 1